Differential effects of PCSK9 inhibitors and statins on plasma ceramides in coronary artery disease

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-12-18
DOI
https://doi.org/10.3389/fphar.2025.1726925
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Differential effects of PCSK9 inhibitors and statins on plasma ceramides in coronary artery disease

Yaodong Ding, Yong Zeng, Liang Zhang
Frontiers in Pharmacology
Lipoproteins and Cardiovascular Health
article

Differential effects of PCSK9 inhibitors and statins on plasma ceramides in coronary artery disease

Yaodong Ding, Yong Zeng, Liang Zhang
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Beijing Anzhen Hospital (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 39%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Differential effects of PCSK9 inhibitors and statins on plasma ceramides in coronary artery disease — Yaodong Ding, Yong Zeng, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS